Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 37 Breast Neoplasms 26 Prostatic Neoplasms 22 Stomach Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 12 Lung Neoplasms 11 Neoplasms 10 Urinary Bladder Neoplasms 8 Head and Neck Neoplasms 8 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Squamous Cell 6 Non-Muscle Invasive Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Transitional Cell 5 Adenocarcinoma 5 Oropharyngeal Neoplasms 4 Sarcoma 3 Prostatic Neoplasms, Castration-Resistant 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Esophageal Squamous Cell Carcinoma 3 Endometrial Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vaccinia 2 Recurrence 2 Peritoneal Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer 2 Melanoma 2

Interventions

Radiosurgery 3 Androgen Antagonists 3 pembrolizumab 1 fludrocortisone acetate 1 enzalutamide 1 darolutamide 1 cabazitaxel 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisone 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Hydrocortisone 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Dexamethasone 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostate Cancer Metastatic × Docetaxel × Clear all

NCT06320067 2025-09-26

STAMPEDE2

University College, London

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡